Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)

NCT06812117 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT06812117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06812117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)
Lead sponsor
Daiichi Sankyo
Phase
Observational
Overall status
Completed
Start date
January 24, 2025
Completion date
April 9, 2026
Enrollment
721 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathic pain